Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting

Peter R. Kowey, Daniel Yannicelli, Ezra A Amsterdam

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

The efficacy and safety of oral propafenone for the prevention of atrial fibrillation (AF) were tested in a group of 293 patients who underwent coronary artery bypass grafting. Patients were randomized to placebo or 1 of 2 doses of propafenone. Patients treated with propafenone 675 mg/day compared with placebo had a nonsignificantly reduced incidence of AF and did not have a reduction in length of stay. Adverse events and discontinuations for untoward events were equal among the 3 groups.

Original languageEnglish (US)
Pages (from-to)663-665
Number of pages3
JournalAmerican Journal of Cardiology
Volume94
Issue number5
DOIs
StatePublished - Sep 1 2004

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting'. Together they form a unique fingerprint.

  • Cite this